The 72nd Scientific Sessions of the American Diabetes Association (ADA) will take place from June 8-12 at the Pennsylvania Convention Center in Philadelphia, PA.
June 8-12 at the
Pennsylvania Convention Center
in Philadelphia, PA.
The 72nd Scientific Sessions of the American Diabetes Association (ADA) will take place from
The comprehensive programming and energized atmosphere of the Scientific Sessions will provide "cutting-edge education and information for all members of the diabetes community—physicians, scientists, nurses, nurse practitioners, dietitians, pharmacists, podiatrists, psychologists, and other health care professionals."
To read more about the sessions and to view an online itinerary planner, please visit the conference page on the ADA website.
To check out all the restaurants, events, museums, and night life Philadelphia has to offer, visit the official visitor's website.
HIVconsvX Vaccine Shows Safety, Immune Response in People on ART
March 10th 2025This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More